Becton, Dickinson and Co

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	55
ISBN Number	not applicable
Product Code	DAT11505

Price

£265.00
approximately: $387 | €290

PDF

PRINT £315 ($460 | €345)

Order above formats by FAX

Summary

Introduction

Becton, Dickinson and Company (BD), a medical technology company, improves drug therapy, enhances the diagnosis of infectious diseases and advances drug discovery. It manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. It serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

BD's business includes medical, diagnostics and biosciences segments. The medical segment produces an array of medical devices including safety engineered injection, infusion therapy devices, pre-fillable drug delivery systems, and surgical blades. The diagnostics segment provides products for the safe collection and transport of diagnostic specimens, and instrumentation for analysis for a range of microbiology and infectious disease testing. The biosciences segment produces research and clinical tools that facilitate the study of cells used to aid in the development of new drugs. BD's historical revenues increased at a CAGR of 10% from 3,960 million to $5,835 million over the historical period 2002-2006, primarily due to sales of medical surgical systems that include sales safety-engineered products and prefilled flush syringes.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Table of Figures
- Tables
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- M&a History
- Atto Bioscience
- Geneohm Sciences
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Geographic Segment Performance
- Products & Services
- Marketed Products
- Bd Vacutainer Push Button Blood Collection
- Ace Elastic Bandages
- Insulin Syringes
- Bd Facscalibur System
- Bd Facscount System
- Diagnostic Systems
- Bd Bactec System
- Bd Facscanto Ii System
- Bd Lsr Ii Flow Cytometer
- Prefillable Injection System
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Product Development
- Global Presence
- Commitment to Productivity Improvements
- Weaknesses
- Weak Performance of Phoenix
- Exit from Blood Glucose Monitoring Market
- Opportunities
- Acquisitions
- Hai Market
- Growing Incidence of Diabetes
- Threats
- Lawsuits
- Deficit Reduction Act
- Industry Consolidation
- Value Chain Analysis
- Overview
- Product Development
- Manufacturing
- Sales
- Key Employees
- List of Employees
- Key Employee Biographies
- Edward J Ludwig
- John R Considine
- Basil L Anderson
- Henry P Becton
- Edward F Degraan
- Gary A Mecklenburg
- James F Orr
- Willard J Overlock
- James E Perrella
- Bertram L Scott
- Adel A.F. Mahmoud
- Alfred Sommer
- Cathy E Minehan
- Claire M Fraser-Liggett
- Marshall O Larsen
- Jeffrey S Sherman
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
List of Tables
- Table 1: Becton, Dickinson and Company - Key Facts
- Table 2: Becton, Dickinson and Company- Locations and Subsidiaries
- Table 3: Becton, Dickinson and Company- Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Becton, Dickinson and Company- Key Events Impacting Share Price Performance
- Table 5: Becton, Dickinson and Company- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Becton, Dickinson and Company- Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 7: Becton, Dickinson and Company- Balance Sheet
- Table 8: Becton, Dickinson and Company- Cash Flow
- Table 9: Becton, Dickinson and Company- Geographic Breakdown, 2002-2006 ($ Mn)
- Table 10: Becton, Dickinson and Company- Marketed Products
- Table 11: Becton, Dickinson and Company- Historical Product Sales, 2002-2006 ($ Mn)
- Table 12: Becton, Dickinson and Company- Forecast Sales, 2006-2010 ($ Mn)
- Table 13: Becton, Dickinson and Company- Key Competitors
- Table 14: Becton, Dickinson and Company- Key Shareholders
- Table 15: Becton, Dickinson and Company- SWOT Analysis Summary
- Table 16: Becton, Dickinson and Company- Value Chain Analysis
- Table 17: Becton, Dickinson and Company- Key Employees
- Table 18: Becton, Dickinson and Company - Financial and Operational Overview
List of Figures
- Figure 1: Becton, Dickinson and Company- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Becton, Dickinson and Company- Key Strateguc Revenues, 2002-2006 ($ Mn)
- Figure 3: Becton, Dickinson and Company- Key Strategic Revenues, 2006-2010 ($ Mn)